NAFDAC REG NO: B4-7805 Médicament
About the medicine: Tropicamide: uses, dosage and brands worldwide
Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.
For mydriasis and cycloplegia for diagnostic procedures.
Contraindicated in persons showing hypersensitivity to any component of this preparation.
For topical ophthalmic use only. Not for injection. This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered. Mydriatics may produce a transient elevation of intraocular pressure. Remove contact lenses before using.
Ocular: Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydriatics. Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardio-respiratory collapse in children have been reported with the use of anticholinergic drugs.
Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.
Label for tropicamide and phenylephrine hydrochloride, the active ingredient registered with NAFDAC.
Add the expiry date on your pack for a full Trust Score.
Trofrine Ophthalmic Solution contains Tropicamide; Phenylephrine Hydrochloride (0.8%; 5%), as eye drops, according to its NAFDAC registration record.
Yes. Trofrine Ophthalmic Solution is listed on the NAFDAC register under registration number B4-7805, and its registration is active as of 4 November 2026.
No WHO falsified or substandard medical product alert currently matches Trofrine Ophthalmic Solution in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number B4-7805, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Follow your prescription or the leaflet in your pack. The official label says: For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 or 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher s…
For mydriasis and cycloplegia for diagnostic procedures. (Summarised from the official U.S. FDA label for tropicamide and phenylephrine hydrochloride. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.